Metraipolis › archive › dc_6db8a2451aff
An Extremely Preterm Infant With PIK3CA-Related Overgrowth Spectrum (PROS): Alpelisib Treatment and Outcome — Europe PMC PMID:41064377
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41064377
- DOI
- 10.1155/crig/6839348
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T17:08:10.830Z
- SHA-256 of the archived text
f651c083dfddd1c06c7692d2b9ac20c7830118d230f22c36c03ab05a7da59728- Stable URL of this page
https://metraipolis.com/documento/dc_6db8a2451aff
How to cite
An Extremely Preterm Infant With PIK3CA-Related Overgrowth Spectrum (PROS): Alpelisib Treatment and Outcome — Europe PMC PMID:41064377 — Europe PMC (en), https://europepmc.org/article/MED/41064377 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6db8a2451aff (Metraipolis archive dc_6db8a2451aff, sha256 f651c083dfddd1c06c7692d2b9ac20c7830118d230f22c36c03ab05a7da59728)
BibTeX
@misc{dc6db8a2451aff,
title = {An Extremely Preterm Infant With PIK3CA-Related Overgrowth Spectrum (PROS): Alpelisib Treatment and Outcome — Europe PMC PMID:41064377},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41064377},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6db8a2451aff; sha256 f651c083dfddd1c06c7692d2b9ac20c7830118d230f22c36c03ab05a7da59728},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41064377. Agents can read the archived copy with the MCP tool read_document.